uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
"Trust is not something you can reclaim easily": patenting in the field of direct-to-consumer genetic testing.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Centre for Research Ethics and Bioethics.
Show others and affiliations
2013 (English)In: Genetics in Medicine, ISSN 1098-3600, E-ISSN 1530-0366, Vol. 15, no 5, 382-7 p.Article in journal (Refereed) Published
Abstract [en]

PURPOSE: Recently, 23andMe announced that it had obtained its first patent, related to "polymorphisms associated with Parkinson's disease" (US-B-8187811). This announcement immediately sparked controversy in the community of 23andMe users and research participants, especially with regard to issues of transparency and trust. The purpose of this article was to analyze the patent portfolio of this prominent direct-to-consumer genetic testing company and discuss the potential ethical implications of patenting in this field for public participation in Web-based genetic research.

METHODS: We searched the publicly accessible patent database Espacenet as well as the commercially available database Micropatent for published patents and patent applications of 23andMe.

RESULTS: Six patent families were identified for 23andMe. These included patent applications related to: genetic comparisons between grandparents and grandchildren, family inheritance, genome sharing, processing data from genotyping chips, gamete donor selection based on genetic calculations, finding relatives in a database, and polymorphisms associated with Parkinson disease.

CONCLUSION: An important lesson to be drawn from this ongoing controversy seems to be that any (private or public) organization involved in research that relies on human participation, whether by providing information, body material, or both, needs to be transparent, not only about its research goals but also about its strategies and policies regarding commercialization.

Place, publisher, year, edition, pages
2013. Vol. 15, no 5, 382-7 p.
National Category
Medical Ethics
URN: urn:nbn:se:uu:diva-245821DOI: 10.1038/gim.2012.143PubMedID: 23174801OAI: oai:DiVA.org:uu-245821DiVA: diva2:791582
Available from: 2015-03-01 Created: 2015-03-01 Last updated: 2015-03-01

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Howard, Heidi
By organisation
Centre for Research Ethics and Bioethics
In the same journal
Genetics in Medicine
Medical Ethics

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 208 hits
ReferencesLink to record
Permanent link

Direct link